These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study. Calderón A, Barrios V, Escobar C, Ferrer E, Barrios S, González-Pedel V, Montoro P, Navarro-Cid J. Clin Exp Hypertens; 2010 May; 32(3):145-53. PubMed ID: 20504121 [Abstract] [Full Text] [Related]
24. Diagnostic performance of electrocardiographic criteria in echocardiographic diagnosis of different patterns of left ventricular hypertrophy. Oikonomou E, Theofilis P, Mpahara A, Lazaros G, Niarchou P, Vogiatzi G, Tsalamandris S, Fountoulakis P, Christoforatou E, Mystakidou V, Anastasiou M, Goliopoulou A, Tousoulis D. Ann Noninvasive Electrocardiol; 2020 May; 25(3):e12728. PubMed ID: 31724804 [Abstract] [Full Text] [Related]
29. Comparison of electrocardiographic criteria for diagnosis of left ventricular hypertrophy in hypertension: the MAVI study. Verdecchia P, Dovellini EV, Gorini M, Gozzelino G, Lucci D, Milletich A, Maggioni AP. Ital Heart J; 2000 Mar; 1(3):207-15. PubMed ID: 10806988 [Abstract] [Full Text] [Related]
30. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Dahlöf B. Hypertension; 2000 Nov; 36(5):766-73. PubMed ID: 11082141 [Abstract] [Full Text] [Related]
31. Electrocardiographic Versus Echocardiographic Left Ventricular Hypertrophy in Severe Aortic Stenosis. Budkiewicz A, Surdacki MA, Gamrat A, Trojanowicz K, Surdacki A, Chyrchel B. J Clin Med; 2021 May 27; 10(11):. PubMed ID: 34072214 [Abstract] [Full Text] [Related]
32. Diagnostic performance of electrocardiographic criteria for left ventricular hypertrophy among various body mass index groups compared to diagnosis by cardiac magnetic resonance imaging. Nomsawadi V, Krittayaphong R. Ann Noninvasive Electrocardiol; 2019 Jul 27; 24(4):e12635. PubMed ID: 30719815 [Abstract] [Full Text] [Related]
33. Ventricular mass and electrocardiographic criteria of hypertrophy: evaluation of new score. Mazzaro Cdo L, Costa Fde A, Bombig MT, Luna Filho B, Paola AA, Carvalho AC, Costa Wd, Fonseca FA, Póvoa RM. Arq Bras Cardiol; 2008 Apr 27; 90(4):227-31. PubMed ID: 18516381 [Abstract] [Full Text] [Related]
34. Cornell product in an electrocardiogram is related to reduced LV regional wall motion. Ishikawa J, Yamanaka Y, Watanabe S, Toba A, Harada K. Hypertens Res; 2019 Apr 27; 42(4):541-548. PubMed ID: 30542082 [Abstract] [Full Text] [Related]
35. The Electrocardiogram Is a Poor Diagnostic Tool to Detect Left Ventricular Hypertrophy in Children: A Comparison with Echocardiographic Assessment of Left Ventricular Mass. Bratincsák A, Williams M, Kimata C, Perry JC. Congenit Heart Dis; 2015 Apr 27; 10(4):E164-71. PubMed ID: 25600360 [Abstract] [Full Text] [Related]
36. ECG identification of left ventricular hypertrophy. Relationship of test performance to body habitus. Okin PM, Roman MJ, Devereux RB, Kligfield P. J Electrocardiol; 1996 Apr 27; 29 Suppl():256-61. PubMed ID: 9238409 [Abstract] [Full Text] [Related]
37. Correlation of electrocardiographic left ventricular hypertrophy criteria with left ventricular mass by echocardiogram in obese hypertensive patients. da Costa W, Riera AR, Costa Fde A, Bombig MT, de Paola AA, Carvalho AC, Fonseca FH, Luna Filho B, Póvoa R. J Electrocardiol; 2008 Apr 27; 41(6):724-9. PubMed ID: 18954613 [Abstract] [Full Text] [Related]
38. Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study. Okin PM, Devereux RB, Jern S, Julius S, Kjeldsen SE, Dahlöf B. Am J Hypertens; 2001 Aug 27; 14(8 Pt 1):775-82. PubMed ID: 11497193 [Abstract] [Full Text] [Related]
39. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Dahlof B, Losartan Intervention for Endpoint reduction in hypertension Study Investigations. Circulation; 2003 Aug 12; 108(6):684-90. PubMed ID: 12885747 [Abstract] [Full Text] [Related]
40. [Comparison of the sensitivity and specificity of the electrocardiography criteria for left ventricular hypertrophy according to the methods of Romhilt-Estes, Sokolow-Lyon, Cornell and Rodríguez Padial]. Cabezas M, Comellas A, Ramón Gómez J, López Grillo L, Casal H, Carrillo N, Camero R, Castillo R. Rev Esp Cardiol; 1997 Jan 12; 50(1):31-5. PubMed ID: 9053944 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]